GLYNNIS THATCH: Open Payments
NPI 1366466492 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 31 payments from 11 companies in 2025. Trend: 2023 $419 · 2024 $601 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $224 |
| Astellas Pharma US Inc | 4 | $81 |
| Lilly USA, LLC | 3 | $60 |
| Abbott Laboratories | 2 | $47 |
| PFIZER INC. | 3 | $47 |
| Exact Sciences Corporation | 2 | $31 |
| ABBVIE INC. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
Products named: Wegovy, Veozah, MOUNJARO, FREESTYLE LIBRE 3, NURTEC ODT, LINZESS, Symbravo, SAPIEN 3 Ultra RESILIA.
Industry payments across IN — which companies pay providers there.
